Showing results (191-200 of 254) with videos related to
Sort By:
Pageof 26
British Journal of Clinical Pharmacology|March 18, 2026
The decline of 6-thioguanine nucleotides is not linked to impaired efficacy or safety of thiopurines in pregnant women with inflammatory bowel diseaseDianne G Bouwknegt, Paola Mian, Femke Groen, et al.Inflammatory Bowel Diseases|February 4, 2021
Outcome of Reverse Switching From CT-P13 to Originator Infliximab in Patients With Inflammatory Bowel DiseaseShaden Mahmmod, Johannes P D Schultheiss, Ad A van Bodegraven, et al.Genome Medicine|January 15, 2015
Complex host genetics influence the microbiome in inflammatory bowel diseaseDan Knights, Mark S Silverberg, Rinse K Weersma, et al.Journal of Crohn'S & Colitis|August 31, 2018
Intestinal Activation of pH-Sensing Receptor OGR1 [GPR68] Contributes to FibrogenesisSenta Hutter, Wouter T van Haaften, Anouk Hünerwadel, et al.BMC Medicine|May 28, 2020
Serum free thiols predict cardiovascular events and all-cause mortality in the general population: a prospective cohort studyAmaal E Abdulle, Arno R Bourgonje, Lyanne M Kieneker, et al.Alimentary Pharmacology & Therapeutics|July 23, 2022
Real-world experience of switching from intravenous to subcutaneous vedolizumab maintenance treatment for inflammatory bowel diseasesAdriaan Volkers, Tessa Straatmijer, Marjolijn Duijvestein, et al.The FEBS Journal|October 19, 2025
Butyrate suppresses mucosal inflammation in inflammatory bowel disease primarily through HDAC3 inhibition in monocytes and macrophagesDaniela Parada-Venegas, Marjorie De la Fuente López, Karen Dubois-Camacho, et al.Inflammatory Bowel Diseases|July 28, 2021
New Therapeutic Approach for Intestinal Fibrosis Through Inhibition of pH-Sensing Receptor GPR4Bruce Weder, Fabian Schefer, Wouter Tobias van Haaften, et al.Gastroenterology|June 28, 2015
Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients With Crohn's DiseaseIlse Molendijk, Bert A Bonsing, Helene Roelofs, et al.Frontiers in Medicine|November 28, 2019
A Combined Set of Four Serum Inflammatory Biomarkers Reliably Predicts Endoscopic Disease Activity in Inflammatory Bowel DiseaseArno R Bourgonje, Julius Z H von Martels, Ruben Y Gabriëls, et al.Pageof 26